{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:11:15Z","timestamp":1791213075591,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Immunology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.smim.2013.10.011","type":"journal-article","created":{"date-parts":[[2013,11,6]],"date-time":"2013-11-06T01:15:17Z","timestamp":1383700517000},"page":"299-304","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Reasons for rarity of Th17 cells in inflammatory sites of human disorders"],"prefix":"10.1016","volume":"25","author":[{"given":"Francesco","family":"Annunziato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Santarlasci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Cosmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Liotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Romagnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.smim.2013.10.011_bib0005","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.iy.07.040189.001045","article-title":"TH1 And TH2 cells: different patterns of lymphokine secretion lead to different functional properties","volume":"7","author":"Mosmann","year":"1989","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.smim.2013.10.011_bib0010","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev.iy.12.040194.001303","article-title":"Lymphokine production by human T cells in disease states","volume":"12","author":"Romagnani","year":"1994","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.smim.2013.10.011_bib0015","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin-17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"5","author":"Harrington","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.smim.2013.10.011_bib0020","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ni1261","article-title":"A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17","volume":"5","author":"Park","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.smim.2013.10.011_bib0025","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1084\/jem.20080397","article-title":"Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor","volume":"205","author":"Cosmi","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.smim.2013.10.011_bib0030","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1182\/blood-2009-04-216085","article-title":"Evidence for a cross-talk between human neutrophils and Th17 cells","volume":"115","author":"Pelletier","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.smim.2013.10.011_bib0035","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.smim.2013.10.011_bib0040","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/ni1496","article-title":"Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells","volume":"8","author":"Acosta-Rodriguez","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.smim.2013.10.011_bib0045","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/ni1497","article-title":"Development, cytokine profile and function of human interleukin 17-producing helper T cells","volume":"8","author":"Wilson","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.smim.2013.10.011_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.immuni.2007.08.013","article-title":"Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells","volume":"27","author":"van Beelen","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2013.10.011_bib0055","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.immuni.2009.02.007","article-title":"Critical regulation of early Th17 cell differentiation by interleukin-1 signaling","volume":"30","author":"Chung","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2013.10.011_bib0060","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature09447","article-title":"Generation of pathogenic T(H)17 cells in the absence of TGF-\u03b2 signalling","volume":"467","author":"Ghoreschi","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.smim.2013.10.011_bib0065","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nature10957","article-title":"Pathogen-induced human T(H)17 cells produce IFN-\u03b3 or IL-10 and are regulated by IL-1\u03b2","volume":"484","author":"Zielinski","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.smim.2013.10.011_bib0070","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1084\/jem.20030896","article-title":"Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation","volume":"198","author":"Murphy","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.smim.2013.10.011_bib0075","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20041257","article-title":"IL-23 drives a pathogenic T cell population that induces autoimmune inflammation","volume":"201","author":"Langrish","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.smim.2013.10.011_bib0080","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1172\/JCI25308","article-title":"Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis","volume":"116","author":"Chen","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.smim.2013.10.011_bib0085","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1084\/jem.20070663","article-title":"Phenotypic and functional features of human Th17 cells","volume":"204","author":"Annunziato","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.smim.2013.10.011_bib0090","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1002\/art.30332","article-title":"Evidence of the transient nature of the Th17 phenotype of CD4+CD161+ T cells in the synovial fluid of patients with juvenile idiopathic arthritis","volume":"63","author":"Cosmi","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.smim.2013.10.011_bib0095","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jaci.2009.10.012","article-title":"Identification of a novel subset of human circulating memory CD4(+) T cells that produce both IL-17A and IL-4","volume":"125","author":"Cosmi","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.smim.2013.10.011_bib0100","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.immuni.2011.12.013","article-title":"Rarity of human T helper 17 cells is due to retinoic acid orphan receptor-dependent mechanisms that limit their expansion","volume":"36","author":"Santarlasci","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2013.10.011_bib0105","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0161-5890(98)00031-5","article-title":"Expressed genes in interleukin-4 treated B cells identified by cDNA representational difference analysis","volume":"35","author":"Chu","year":"1998","journal-title":"Mol Immunol"},{"key":"10.1016\/j.smim.2013.10.011_bib0110","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1182\/blood-2006-07-036210","article-title":"Human IL4I1 is a secreted l-phenylalanine oxidase expressed by mature dendritic cells that inhibits T-lymphocyte proliferation","volume":"110","author":"Boulland","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.smim.2013.10.011_bib0115","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/ni730","article-title":"Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells","volume":"2","author":"Tzachanis","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1016\/j.smim.2013.10.011_bib0120","doi-asserted-by":"crossref","first-page":"8477","DOI":"10.1158\/0008-5472.CAN-06-1603","article-title":"Degradation of Tob1 mediated by SCFSkp2-dependent ubiquitination","volume":"66","author":"Hiramatsu","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.smim.2013.10.011_bib0125","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1073\/pnas.0406789102","article-title":"Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation","volume":"102","author":"Huang","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.smim.2013.10.011_bib0130","doi-asserted-by":"crossref","first-page":"30888","DOI":"10.1074\/jbc.M111.253500","article-title":"STAT3 protein promotes T-cell survival and inhibits interleukin-2 production through up-regulation of Class O forkhead transcription factors","volume":"286","author":"Oh","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.smim.2013.10.011_bib0135","doi-asserted-by":"crossref","first-page":"11839","DOI":"10.1073\/pnas.0805065105","article-title":"Abrogation of T cell quiescence characterizes patients at high risk for multiple sclerosis after the initial neurological event","volume":"105","author":"Corvol","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.smim.2013.10.011_bib0140","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1084\/jem.20121611","article-title":"Tob1 plays a critical role in the activation of encephalitogenic T cells in CNS autoimmunity","volume":"210","author":"Schulze-Topphoff","year":"2013","journal-title":"J Exp Med"},{"key":"10.1016\/j.smim.2013.10.011_bib0145","first-page":"823","article-title":"Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease","volume":"150","author":"Parronchi","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1016\/j.smim.2013.10.011_bib0150","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/ni.1899","article-title":"Effector T cell plasticity: flexibility in the face of changing circumstances","volume":"11","author":"Murphy","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.smim.2013.10.011_bib0160","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1002\/eji.201242648","article-title":"Distinctive features of classic and nonclassic (Th17 derived) human Th1 cells","volume":"42","author":"Maggi","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.smim.2013.10.011_bib0165","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.it.2012.05.004","article-title":"Defining the human T helper 17 cell phenotype","volume":"33","author":"Annunziato","year":"2012","journal-title":"Trends Immunol"},{"key":"10.1016\/j.smim.2013.10.011_bib0170","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.immuni.2011.09.019","article-title":"Th17 cells are long lived and retain a stem cell-like molecular signature","volume":"35","author":"Muranski","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2013.10.011_bib0175","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1084\/jem.20080159","article-title":"IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition","volume":"205","author":"Kroenke","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.smim.2013.10.011_bib0180","doi-asserted-by":"crossref","first-page":"329","DOI":"10.4049\/jimmunol.181.1.329","article-title":"Development of proteoglycan-induced arthritis is independent of IL-17","volume":"181","author":"Doodes","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.smim.2013.10.011_bib0185","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1084\/jem.20071258","article-title":"Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category","volume":"205","author":"Luger","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.smim.2013.10.011_bib0190","first-page":"61","article-title":"IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice","volume":"119","author":"Haak","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.smim.2013.10.011_bib0195","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/eji.200838475","article-title":"Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells","volume":"39","author":"Martin-Orozco","year":"2009","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.smim.2013.10.011_bib0200","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1172\/JCI37865","article-title":"Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD\/SCID recipient mice","volume":"119","author":"Bending","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.smim.2013.10.011_bib0205","doi-asserted-by":"crossref","first-page":"4478","DOI":"10.4049\/jimmunol.1203172","article-title":"Cutting Edge: the pathogenicity of IFN-\u03b3-producing Th17 cells is independent of T-bet","volume":"190","author":"Duhen","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.smim.2013.10.011_bib0210","article-title":"T-bet is essential for Th1-mediated, but not Th17-mediated, CNS autoimmune disease","volume":"July","author":"O\u2019Connor","year":"2013","journal-title":"Eur J Immunol"},{"issue":"July","key":"10.1016\/j.smim.2013.10.011_bib0215","article-title":"Highly polarized Th17 cells induce EAE via a T-bet independent mechanism","author":"Grifka-Walk","year":"2013","journal-title":"Eur J Immunol"}],"container-title":["Seminars in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532313000924?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532313000924?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T01:26:46Z","timestamp":1539221206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044532313000924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S1044532313000924"],"URL":"https:\/\/doi.org\/10.1016\/j.smim.2013.10.011","relation":{},"ISSN":["1044-5323"],"issn-type":[{"value":"1044-5323","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reasons for rarity of Th17 cells in inflammatory sites of human disorders","name":"articletitle","label":"Article Title"},{"value":"Seminars in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.smim.2013.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}